Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients
Abstract The expression of mesothelin correlates with a poor prognosis in patients with breast cancer. Since mesothelin plays a role in cancer metastasis in association with CA125, we herein examined the expression of mesothelin and CA125, and the clinicopathological meaning and prognosis of the co-...
Saved in:
Main Authors: | Takahiro Einama (Author), Yoji Yamagishi (Author), Yasuhiro Takihata (Author), Takafumi Suzuki (Author), Tamio Yamasaki (Author), Yuichi Hirose (Author), Kazuki Kobayashi (Author), Naoto Yonamine (Author), Ibuki Fujinuma (Author), Takazumi Tsunenari (Author), Makiko Koga (Author), Yusuke Ishibashi (Author), Ken Nagata (Author), Takehiro Shiraishi (Author), Akiko Nakazawa (Author), Toshimitsu Iwasaki (Author), Eiji Shinto (Author), Kimi Kato (Author), Kimiya Sato (Author), Hideki Ueno (Author), Yoji Kishi (Author), Hitoshi Tsuda (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis
by: Soichiro Kakimoto, et al.
Published: (2021) -
Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas
by: Onur Oral, et al.
Published: (2020) -
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
by: Fernanda Cardoso da Silva, et al.
Published: (2023) -
Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
by: Zhen Li, et al.
Published: (2020) -
The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
by: Yu Yi, et al.
Published: (2011)